Fulcrum Therapeutics Inc (FULC)

Stock-Based Compensation

$13.56M

TTM · Period ending: · USD

FULC logo

FULC Stock-Based Compensation

Latest reported$13.56M
FULC TTM Stock-Based Comp ($2.16M → $13.56M)
High-resolution chart · PNG

FULC stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fulcrum Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
13,557,000
13,161,000
12,468,000
11,879,000
12,336,000
13,805,000
14,554,000
15,526,000
15,446,000
14,465,000
14,802,000
14,624,000
14,240,000
13,756,000
13,350,000
13,872,000
13,177,000
12,844,000
11,070,000
8,954,000
8,072,000
7,730,000
7,350,000
6,947,000
6,350,000
5,096,000
4,224,000
3,712,000
3,039,000
2,551,000
2,159,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.